Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Kleinman, P. Chan, P. Robillard (2003)
Risks associated with transfusion of cellular blood components in Canada.Transfusion medicine reviews, 17 2
R. Dodd, E. Notari, S. Stramer (2002)
Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor populationTransfusion, 42
Richard Aach, Wolf Szniuness (1981)
Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study.The New England journal of medicine, 304 17
Alter Alter, Purcell Purcell, Holland Holland (1981)
The relationship of donor transaminase to recipient hepatitis: impact on blood transfusion servicesJAMA, 246
H. Alter, R. Purcell, P. Holland, D. Alling, D. Koziol (1981)
Donor transaminase and recipient hepatitis. Impact on blood transfusion services.JAMA, 246 6
S. Kleinman, S. Glynn, M. Busch, D. Todd, Laurie Powell, L. Pietrelli, G. Nemo, G. Schreiber, C. Bianco, L. Katz (2005)
The 2003 West Nile virus United States epidemic: the America's Blood Centers experienceTransfusion, 45
L. Pealer, A. Marfin, L. Petersen, R. Lanciotti, P. Page, S. Stramer, M. Stobierski, K. Signs, B. Newman, H. Kapoor, J. Goodman, M. Chamberland (2003)
Transmission of West Nile virus through blood transfusion in the United States in 2002.The New England journal of medicine, 349 13
Voak, Caffrey, Barbara, Pollock, Scott, Contreras (1998)
Affordable safety for the blood supply in developed and developing countriesTransfusion Medicine, 8
R. Dodd (2003)
Emerging infections, transfusion safety, and epidemiology.The New England journal of medicine, 349 13
American Red Cross Blood Services, Greater Chesapeake and Potomac Region: C.C. Nass
American Red Cross (as subcontractor from the CDC to Florida Blood Services
Dodd Dodd (2003)
Emerging infections, transfusion safety, and epidemiology (perspective)N Engl J Med, 349
Kleinman Kleinman (2001)
A review of HGV biology, epidemiology, and clinical manifestations with emphasis on implications for blood safetyTransfus Med Rev, 15
M. Turner, C. Ludlam (2000)
Variant Creutzfeldt-Jakob disease.Transfusion medicine reviews, 14 3
M. Busch, S. Kleinman, G. Nemo (2003)
Current and emerging infectious risks of blood transfusions.JAMA, 289 8
Murphy, Busch, Tong, Cornett, Vyas (1998)
A prospective study of the risk of transfusion‐acquired viral infectionsTransfusion Medicine, 8
E. Donegan, M. Stuart, J. Niland, H. Sacks, S. Azen, S. Dietrich, C. Faucett, M. Fletcher, S. Kleinman, E. Operskalski, H. Perkins, J. Pindyck, E. Schiff, D. Stites, P. Tomasulo, J. Mosley (1990)
Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations.Annals of Internal Medicine, 113
E. Donegan, H. Lee, E. Operskalski, G. Shaw, S. Kleinman, M. Busch, C. Stevens, E. Schiff, M. Nowicki, C. Hollingsworth, J. Mosley (1994)
Transfusion transmission of retroviruses: human T‐lymphotropic virus types I and II compared with human immunodeficiency virus type 1Transfusion, 34
R. Aach, C. Stevens, F. Hollinger, J. Mosley, D. Peterson, P. Taylor, Rhonda Johnson, L. Barbosa, G. Nemo (1991)
HEPATITIS C VIRUS INFECTION IN POST-TRANSFUSION HEPATITIS - AN ANALYSIS WITH FIRST - AND SECOND - GENERATION ASSAYSThe New England Journal of Medicine, 325
H. Alter, R. Purcell, J. Shih, J. Melpolder, M. Houghton, Q. Choo, G. Kuo (1989)
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.The New England journal of medicine, 321 22
T. Umemura, A. Yeo, A. Sottini, D. Moratto, Yasuhito Tanaka, R. Wang, J. Shih, Peter Donahue, D. Primi, H. Alter (2001)
SEN virus infection and its relationship to transfusion‐associated hepatitisHepatology, 33
American Red Cross Blood Services Southern California Region: G. Garratty, S. Hutching Blood Centers of the Pacific
Steven Kleinman (2001)
Hepatitis G virus biology, epidemiology, and clinical manifestations: Implications for blood safety.Transfusion medicine reviews, 15 3
J. Allain (2000)
Emerging viral infections relevant to transfusion medicine.Blood reviews, 14 4
H. Schennach, D. Schönitzer, H. Wachter, D. Fuchs (1997)
Blood donations and virusesThe Lancet, 349
Smith CDC-sponsored blood centers: Institute for Transfusion Medicine
H. Alter, Y. Nakatsuji, J. Melpolder, J. Wages, R. Wesley, J. Shih, J. Kim (1997)
The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.The New England journal of medicine, 336 11
BACKGROUND: An ongoing issue in transfusion medicine is whether newly identified or emerging pathogens can be transmitted by transfusion. One method to study this question is through the use of a contemporary linked donor‐recipient repository. STUDY DESIGN AND METHODS: The Retrovirus Epidemiology Donor Study Allogeneic Donor and Recipient (RADAR) repository was established between 2000 and 2003 by seven blood centers and eight collaborating hospitals. Specimens from consented donors were collected, components from their donations were routed to participating hospitals, and recipients of these units gave enrollment and follow‐up specimens for long‐term storage. The repository was designed to show that zero transmissions to enrolled recipients would indicate with 95 percent confidence that the transfusion transmission rate of an agent with prevalence of 0.05 to 1 percent was lower than 25 percent. RESULTS: The repository contains pre‐ and posttransfusion specimens from 3,575 cardiac, vascular, and orthopedic surgery patients, linked to 13,201 donation specimens. The mean number of RADAR donation exposures per recipient is 3.85. The distribution of components transfused is 77 percent red cells, 13 percent whole blood–derived platelet concentrates, and 10 percent fresh frozen plasma. A supplementary unlinked donation repository containing 99,906 specimens from 84,339 donors was also established and can be used to evaluate the prevalence of an agent and validate assay(s) performance before accessing the donor‐recipient–linked repository. Recipient testing conducted during the establishment of RADAR revealed no transmissions of human immunodeficiency virus, hepatitis C virus, or human T‐lymphotropic virus. CONCLUSIONS: RADAR is a contemporary donor‐recipient repository that can be accessed to study the transfusion transmissibility of emerging agents.
Transfusion – Wiley
Published: Jul 1, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.